Clinical trials
Active, not recruiting Anemia trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Agios Pharmaceuticals, Inc. | 3 |
| Bristol-Myers Squibb | 3 |
| Celgene | 2 |
| National Cancer Institute (NCI) | 2 |
| Brigham and Women's Hospital | 1 |
| Cure HHT | 1 |
| Editas Medicine, Inc. | 1 |
| Forma Therapeutics, Inc. | 1 |
| George Washington University | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia | 20 |
| Myelodysplastic Syndromes | 7 |
| Hematologic Diseases | 5 |
| Anemia, Hemolytic | 2 |
| Anemia, Sickle Cell | 2 |
| Genetic Diseases, Inborn | 2 |
| Hemoglobinopathies | 2 |
| Metabolic Diseases | 2 |
| Myeloproliferative Disorders | 2 |
| Primary Myelofibrosis | 2 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.